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Title: The impact of adolescence initiated alcohol and cannabis abuse/dependence on the 
level of activity participation in adult males suffering from a psychotic disorder. 
Background: Individuals suffering from both a psychotic disorder and a substance abuse 
disorder have shown to have poorer occupational outcomes. This study aimed at 
determining the exact consequences of substance abuse on occupational performance in 
order to tailor more specific treatment interventions in the future. 
Methodology:  A non-experimental design and observational study was used. This 
involved a once off occupational therapy assessment using the Activity Participation 
Outcome Measure (APOM) as the recoding tool. The participants were divided into three 
groups: Alcohol abuse, cannabis abuse and no substance abuse. 
Results: A statistically significant difference was noted between the alcohol and cannabis 
groups. The alcohol group achieved a higher level of activity participation in all eight 
APOM domains (Role performance, life skills, communication, motivation, process skills, 
self esteem, balanced lifestyle, and affect). The no substance abuse group (individuals 
diagnosed with schizophrenia) showed the lowest level of activity participation. 
Conclusion: Cannabis adolescent abuse/dependence appears to have a more negative 
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Occupational Performance: Occupational performance involves the dynamic 
interaction between the person, his/her occupations and the environment. It refers to the 
hierarchy of roles or activities which organises the individual’s daily occupations. (17) 
Activity Participation: Involvement in a life situation through performing a class of 
human actions which are goal directed. Three sub constructs present this construct 
namely client factors, occupational performance skills and well-being.  (79) 
Activity Participation Outcome Measure (APOM):  Occupation based outcome 
measure used to record an individual’s level of activity participation.  (79) 
Montreal Cognitive Assessment of Minnesota (MOCA): Bed side screening tool used 
to assess an individual’s basic cognitive abilities. (77) 
Substance: A substance refers to a psychoactive agent which is either ingested orally, 
intravenously or inhaled and is used for non-medical indications. (6) 
Substance Abuse/Dependence: Substance abuse and dependence are defined as 
both involving a maladaptive pattern of substance use leading to clinically significant 
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CHAPTER 1  Introduction 
 
1.1 Introduction 
The psychiatric unit at Chris Hani Baragwanath Academic Hospital (CHBAH) is involved 
in treating individuals presenting with a variety of psychiatric diagnoses. It is an acute 
state psychiatric unit accommodating 100 – 150 patients and the referral patterns show 
that approximately 30 to 40 of these patients attend occupational therapy per week. In 
this setting, the most common diagnoses observed within the male patient population 
are either a primary psychotic disorder or a substance induced psychotic disorder. 
Approximately 50% of patients present with a combination of the above disorders and 
are therefore classified as having a dual diagnosis. Patients suffering from a dual diagnosis 
within this setting have been observed to be typically male and presenting to the 
psychiatric unit at approximately 20 to 25 years of age. Alcohol and cannabis abuse have 
been observed to be the most common and most debilitating amongst the CHBAH 
attending patients. 
The Zamani Clinic at CHBAH is dedicated to assisting these patients to stabilise both 
their psychiatric disorder through psychotropic medication as well as assisting through 
various psychological and occupational interventions, to abstain from substances and 
alcohol. Clinical experience has shown a high relapse rate amongst these patients, poor 
compliance to medication, poor compliance to both psychological and occupational 
interventions and a noticeable deterioration in occupational performance within all of the 
areas of occupational performance. 
The literature  has also been documented that patients suffering with a dual diagnosis 
have been shown to have poorer occupational outcomes, an increase in psychotic 
symptoms, poorer treatment compliance, increased violence, increased hospitalization  
and a higher rate of relapse and non compliance as compared to individuals with a purely 
psychiatric or substance abuse disorder. (1, 2) Numerous studies have documented the 
decline in neurocognitive functioning and relapse rate, (3, 4) but the impact on other 
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areas of activity participation such as forming interpersonal relationships, life skills, 
coping skills, self esteem, vocational skills and the ability to maintain a balanced lifestyle 
are not well documented. 
Limited documented evidence based research into the wide range of negative 
consequences of the certain substances when used in combination with the presence of a 
psychiatric diagnosis, has restricted the full understanding of dual diagnosis and may be 
hindering the development of specific and integrated intervention programmes. This may 
be contributing to the high rate of relapse, poorer occupational outcomes noted in this 
population and documented literature. Without integrated and specific intervention 
programmes, individuals suffering from a dual diagnosis may not be receiving optimal, 
holistic treatment which will further compromise their prognosis and ability to return to 
their baseline level of functioning. A first step in remediating the various challenges and 
targeting specific interventions in a specialist clinic, is to document areas of deficit that 
need to be focused on. 
1.2 Research Question 
Does the initiation of alcohol or cannabis abuse/dependence during the adolescent 
years, have an impact on the level of activity participation into adulthood in individuals 
suffering from a psychotic disorder, at Chris Hani Baragwanath Academic Hospital? 
1.3 Aim 
To determine the impact of adolescence initiated alcohol and cannabis 
abuse/dependence on the level of adult activity participation in males between the ages 
of 19-29 years diagnosed with a psychotic disorder. 
1.4 Null Hypothesis (H0) 
There is no impact of alcohol/cannabis use on the level of activity participation of 





 To determine and describe the level of activity participation in adult males (19-
29 years) presenting with the following three disorders: 
o A psychotic disorder,  
o  Adolescent-initiated alcohol abuse/dependence with psychosis. 
o Adolescent- initiated cannabis abuse/dependence with psychosis. 
 To compare the impact of alcohol and cannabis abuse/dependence on activity 
participation in adult males (19-29 years) presenting with a psychotic disorder 
to psychotic disorders without substance-initiated abuse/dependence. 
1.6 Justification of Study 
The focus of this study was to assess the impact of substance use, initiated in 
adolescence, on activity participation in men with a dual diagnosis. Evidence of the 
negative consequences of substances on all areas of occupational performance could 
enhance occupational therapists’ understanding of dual diagnosis. The main purpose of 
having an evidence based understanding of the consequences of substance abuse is to 
assist occupational therapists addressing treatment aspects such as insight and 
compliance and developing interventions, which can be more specific to this particular 
population’s needs. This research is intended to produce improved functional and clinical 
outcomes for this population.  
1.7 Organization of Report 
This report has been organized into five chapters. The first chapter is titled the 
introduction and describes the background to the research aim, the research question 
and objectives put forward by the researcher. Chapter two is the literature review and 
presents the recent findings and developments within the field of psychosis and 
substance abuse. Chapter three describes the methodology and the process which the 
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researcher followed in order to accurately answer the research question. Chapter four 
reports the results that were determined from the study. Chapter five the discussion puts 
forward the impact of the results on clinical practice and chapter six concludes the major 
findings and implications of the study. 
1.8 Conclusion 
The main research question and objectives of the study have been described in 
chapter one. The following chapter will discuss the major trends and developments noted 
within the literature surrounding psychosis, substance abuse and the impact on level of 
















CHAPTER 2  Literature review 
 
2.1 Introduction 
Substance abuse among adolescents has been a public health problem for decades 
with alcohol and cannabis being shown to be the most common substances abused within 
the South African population. General use of substances is usually triggered by 
experimentation and this leads to the abuse of the substance. Abuse of a substance is 
where the individual continues to use the substance, despite knowing the harmful and 
dangerous effects of the substance (5, 6). The concern for health care providers is that 
these individuals who experiment with substances are at risk to develop substance 
induced mood/psychotic disorders. Many psychiatric hospitals with acute units, report a 
high number of substance use disorders between the ages of 19 – 29 years (5). 
This chapter reports on the challenges in distinguishing between substance use 
disorders, concerns regarding adolescent development, consequence on activity 
participation and treatment interventions with regard to alcohol and cannabis 
abuse/dependence. 
2.2 Statistics on Substance Abuse in South Africa 
Statistics published in the United Nations World Drug Report 2011 indicated South 
Africa as being one of the drug capitals of the world (7). Drug consumption is twice that of 
the world norm, with 15% of the population having a drug problem. The report indicated 
that tobacco, alcohol and cannabis were the most common substances abused within the 
South African population. The use of cannabis has increased by 20%. In 2006 2.52 million 
people used cannabis and this increased to 3.2 million in 2008 (7). Drug abuse is costing 
the government approximately R20-billion a year and could pose a bigger threat to the 
country's future than the Aids pandemic (7). According to South African Police Service, 60 
percent of crimes nationally were related to substance abuse. (7) 
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Figure 2.1: Level of Cannabis Use in South Africa 
 
Figure 2.1 shows that South Africa has one of the highest levels of cannabis use with 
more than 8% of the population using cannabis and South Africa is also one of the main 
cultivation areas in the world. (8) 
2.3 The Prevalence of Substance Use among South African Youth 
As in the United States, adolescent substance use and abuse are ongoing problems in 
South Africa.(9) The starting age of substance abuse in South Africa is twelve years or 
younger. From 1992 - 95 the use of drugs among teenagers increased by 600% and this 
figure is continuing to rise. Currently, one in two children in the average South African 
home are addicted to drugs or alcohol or run the risk of becoming addicted.(7) 
By the 8th grade, approximately 26% children are alcohol users and by the 11th grade 
40%. Additionally, 26% of 8th graders and 29% of 11th graders report binge drinking which 
suggests that many South African adolescents who drink alcohol, are doing so in a risky 
manner. (10)  
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The high prevalence of alcohol use in South Africa also is of concern given that use of 
these substances often precedes illicit drug use and that early and excessive substance 
use in adolescence predicts later abuse.(11, 12) 
2.4 Challenges in Substance Diagnosis 
Psychiatric symptoms have been, for over 50 years, grouped together to form certain 
syndromes or diagnoses in order to help simplify thinking, improve communication 
between clinicians, predict outcomes, determine treatment and assist in determining the 
etiology of the symptoms. The American Psychiatric Association and the World Health 
Organization have published summaries on all the diagnoses used in psychiatry. The most 
commonly used in South Africa is the Diagnostic and Statistical Manual of Mental 
Disorders (DSM IV), the fourth edition of which  was used in this study as the fifth version 
was not yet published at the commencement of this study. In this manual it clearly 
defines and indicates the symptoms and signs present in substance abuse or dependence 
as well as the symptoms present in the various psychotic disorders. (6, 13) 
2.4.1 Substance Abuse versus Substance Dependence 
Substance abuse and substance dependence disorders are regarded as chronic, 
episodic and often relapsing. They occur along a spectrum from use to misuse to abuse 
and finally dependence. The use of a substance may or may not be clinically significant. 
Misuse is clinically significant but does not meet the criteria for abuse or dependence.(6) 
The DSM IV defines substance use disorders as either abuse or dependence.  
Substance abuse and dependence are both defined as involving a maladaptive pattern 
of substance use leading to clinically significant impairment or distress. The number of 
symptoms occurring within a 12-month period determines the level of abuse or 





Table2.1: DSM-IV criteria for Substance abuse and dependence (6) 
Substance Abuse Substance Dependence 
One or more of the following occurring within a 12 month 
period: 
Three or more of the following occurring within a 12 
month period. 
Failure to fulfil major role obligations Tolerance 
Using in physically hazardous situations Withdrawal 
Incurring legal problems Majority of time is spent around the substance 
Persistent and recurrent social problems Decreased or loss of other occupational activities 
 In spite of these consequences there is a failure by the 
individual to abstain from the substance 
 
A variety of substance-induced disorders may also occur. These include intoxication, 
withdrawal, delirium, persisting dementia, persisting amnesic disorder, psychotic 
disorder, mood disorder, anxiety disorder, sexual dysfunction disorder and sleep 
disorders.(6, 13) 
The distinction between substance abuse and dependence is therefore mostly based 
on the clinician’s subjective interpretation of the individual’s level of functioning and 
impact of the substance use on the ability to engage in daily life tasks. This does make the 
distinction not entirely accurate and can be interpreted differently between different 
clinicians. (14) This has lead to the change in the criteria in DSM 5 where the distinction 
between abuse and dependence is no longer made. Tolerance and withdrawal symptoms 
are now indicated as being markers for substance use disorders in distinguishing between 
abuse and dependence. The individual is classified only as having a substance use 
disorder and the severity is then classified based on the number of symptoms to which 
the individual accounts for. This will allow for communication and more uniform diagnosis 
between clinicians in the future.(15) 
The progression from misuse to either abuse or dependence is not entirely 
understood. A strong genetic vulnerability has been documented but there is also the 
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combination of social and environmental factors which play a role. Research has indicated 
that early regular drinking has shown to be associated with later alcohol dependence and 
use and abuse or dependence on other drugs. The link, however, is not entirely explained 
by genetic or shared family environmental factors. Research has therefore also suggested 
that unique environmental factors contribute to transitions from early regular alcohol 
drinking to use, abuse and dependence on alcohol and other substances.(13, 16) 
2.5 Adolescence 
Adolescence is derived from the Latin term adolescere meaning to grow into 
adulthood (17). It is the time between childhood and adulthood ranging from 12-18 years 
of age for girls and 13-20 years old for boys. It is the transition from a child into a mature 
adult bringing with it its recognition by society and accompanying responsibilities. The 
major concern around this stage of development is the impact of substance use on both 
the physical and psychological functioning of the adolescent.(17) 
Plastic and dynamic processes drive adolescent brain development, creating flexibility 
that allows the brain to refine itself, specialize, and sharpen its functions for specific 
demands. Maturing connections enable increased communication between brain regions, 
allowing greater integration and complexity. (18) 
Various physical, cognitive, emotional and social developments occur in this stage. 
Physical changes include increase in the growth rate, increase in body size, hormonal 
changes as well as the development of sexual characteristics. Cognitive development 
involves the development of thought processes including imagination, judgment, insight 
and abstract thought. Adolescents develop their own value systems, think more critically, 
develop their own plans, speculate, evaluate their thoughts, solve complex problems and 
become more open and creative thinkers.(17) The myelination of the parietal lobes allow 
for the development of abstract thought however both inhibition and judgment only 
develop in the later years of this stage. Emotional changes are linked to the various 
hormonal, physical and cognitive developments that occur during adolescence. This may 
generate emotional lability and uncertainty around thoughts and feelings (18).  
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Social development is the aspect which is of fundamental importance during the 
adolescent stage. The peer group becomes extremely important and allows for 
experimenting with different behaviours and relationships. The adolescent learns a sense 
of self separate from parent. These social interactions generate a sense of belonging, 
allow for the development of personal identity and create the foundation for the 
development of more mature interpersonal relationships in the future.(17)  
2.6 Risk Factors to Substance Abuse 
A variety of factors have been noted which lead to an increased risk of substance 
abuse amongst adolescents. These include developmental, social, genetic, individual and 
contextual factors (16). Developmental factors include adjusting to body changes, 
negative peer influences, handling the decrease in parental influence, developing 
individuality, and constructing abstract thoughts but with limited judgment and insight 
(16). Social factors include family influences or dysfunction, exposing media, deviant peer 
group, family history of substance abuse and parental attitudes (16). Psychological factors 
include low self esteem, thrill seeking behaviour, co morbid Attention Deficit 
Hyperactivity Disorder, conduct disorder, depression or other mental illnesses, self 
medicating behaviour, or difficulty fitting in to peer group.(16, 18) Genetics may also play 
a role in terms of risk factors by an individual having a genetic vulnerability in terms of a 
relative also presenting with a substance use disorder or mental illness. (16) Research, 
however, has shown that risk factors including disinhibition, cognitive structure, play, 
deviant coping, friends' deviance and stressful life events are not solely responsible, but 
also individual and normative changes during the transition from adolescence to 
adulthood play a role in increasing the risk for drug use.(19) Social networks play a vital 
role in the early initiation of substances and the use of the substance is sustained by less 
time spent with parents and more with drug-using peers.(20) Specific to the South African 
context, the majority of the population reside in rural areas with limited resources and 
also the high number of social problems including violence, crime, poverty and 
gangsterism which exist. The lack of resources restricts the adolescent’s ability to engage 
in constructive leisure activities and therefore adolescents experience high rates of 
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boredom and passivity during their leisure time. This compounds the risk of potential 
substance abuse within the adolescent South African population.(17) 
2.7 Activity Participation 
Activity participation involves the individual engaging in a variety of meaningful, 
purposeful, and goal directed activities which makes up their own personal life situations 
and provide a sense of wellbeing. To achieve a high level of activity participation would 
indicate good health and wellbeing. A lower level of activity participation would indicate 
some form of deficit or impairment that is hindering the individual from being able to 
carry out his/her daily life tasks or roles.  
Due to the developmental processes which are still occurring during adolescence, the 
abuse of substances in this stage is noted to cause more adverse long term consequences 
on the individuals level of activity participation.(21) Adolescents involved in substance 
abuse are at an increased risk of road accidents, personal accidents, decline in cognitive 
functioning (17), school failure, poor judgment, violence, unplanned and unsafe sex, and 
suicide. (22) Studies have indicated that adolescent substance abusers experience higher 
rates of boredom during their leisure time than non substance abusers.(23, 24) 
Psychoactive substances and alcohol have been implicated in altering neural circuits 
involved in the dopamine reward-related regions in the brain and therefore contributing 
to substance dependence later in life.(25) Substance abuse may also lead to neurotoxicity 
where irreversible cell death occurs in the brain as well as the perpetuation or 
precipitation of a mental illness. This indicates that any substance abuse which occurs 
during this time will have a greater negative consequence on the brain and the level of 
activity participation, than in adulthood.(21) 
2.7.1 Effects of Alcohol on Activity Participation 
As described above, the brain areas which are actively developing during adolescence 
include the prefrontal cortex, limbic system areas, and white matter myelin (26). These 
areas are involved in cognitive and behavioural development, and emotional regulation 
which may, therefore, be particularly vulnerable to the adverse and damaging effects of 
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alcohol.(26) Thus plausible it is to link alcohol exposure during the critical adolescent 
developmental stages to disruption of the brain plasticity and maturation processes, 
resulting in behavioural and cognitive deficits.(18) 
Emerging trends from developmentally focused research have  indicated that there 
are subtle but important neurocognitive disadvantages among adolescents with alcohol-
use disorders as compared to adolescents without alcohol use disorders.(27) There is a 
noted reduction in attention, executive functions,(21) working memory, problem solving, 
patterns of regional brain activation, and gray and white matter volume.(27) The long-
term neurocognitive consequences of early alcohol consumption are not readily 
understood.(28) However, prolonged visual–spatial and cognitive dysfunction has been 
reported into adulthood. (29) The neurocognitive decline has been linked to three 
variables which have been shown to have a significant impact on cognitive sensitivity to 
alcohol and they are: age of first alcohol use (age of drinking initiation); specific pattern of 
alcohol consumption and being male gender.(28) 
There is evidence to suggest that alcohol dependence is a primary cause of 
impairments in overall quality of life, general health, mental and physical health and 
social functioning. (30) Patients meeting criteria for alcohol dependence have scored 
lower on quality of life, mental health (31) and levels of daily functioning scales.(32) 
2.7.2 Effects of Cannabis on Activity Participation 
Substance use has a wide range of negative effects on health, psychosomatic 
symptoms, emotional distress, and interpersonal relationships. (33) 
The most likely adverse physical effects of regular cannabis use include a substance 
dependence syndrome, increased risk of motor vehicle accidents, impaired respiratory 
function, cardiovascular disease, and adverse effects on adolescent psychosocial 
development and mental health.(8) 
Studies have indicated adverse psychosocial consequences in terms of early 
adolescent cannabis use increasing the risk in late adolescence of not graduating from 
 13 
 
high school; delinquency; having multiple sexual partners; not always using condoms; 
perceiving drugs as not harmful; having problems with cigarettes, alcohol; and having 
more friends who exhibit deviant behaviour. It hinders the acquisition of skills necessary 
for employment and heightens the risks of contracting HIV, crime, depression, suicidal 
behaviours and abusing legal and illegal substances.(34-36) 
Other factors which have been linked to cannabis use include lower educational and 
occupational expectations, being suspended or expelled from school, failure to enter 
university, failure to obtain a university degree, fired from jobs, collecting disability 
grants, rebelliousness, not participating in productive activities, not attending church, and 
being an unmarried parent. Cannabis users show a poor performance on developmental 
tasks which are integral in becoming an independent and responsible young adult.(37-39) 
Long term cannabis use shows adverse consequences to individuals cognitive 
functioning with studies demonstrating impairment in memory and attention which lasts 
beyond intoxication and worsens with increasing years of regular use. (40-42) 
Chronic cannabis use has also been associated with an 'amotivational syndrome,' in 
which individuals have limited motivation and drive to engage in activities which further 
compounds their cognitive impairments and occupational functioning.(42, 43)  
The most debilitating consequence of cannabis abuse is the development of a severe 
mental illness such as schizophrenia or other psychotic disorders, which has been strongly 
associated with alcohol and cannabis abuse. (44-46) Cannabis use has been shown to 
increase the speed of onset of psychosis and prodromal symptoms of schizophrenia. (6, 
47) 
It is documented that substance abuse and dependence is common amongst people 
with severe mental disorders such as schizophrenia. (1) This therefore, suggests that the 
psychiatric disorder may exist before the substance abuse disorder in which case the 
substance abuse disorder will compound the situation and further increase the severity of 
the other psychiatric disorder.(48, 49) 
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2.7.3 Impact of Psychosis on Activity Participation 
According to the American Heritage Medical Dictionary of 2007, a psychotic disorder 
has been defined as a severe mental disorder which is characterized by the derangement 
of personality, loss of contact with reality and a prominent deterioration in normal social 
and occupational functioning. (50) 
One of the most common psychotic disorders is schizophrenia which has been 
described as a severe disorder that often has a significant impact on the lives of individual 
sufferers.(6)  
Patients suffering from a psychotic disorder display a wide range of deficits across 
neurocognitive domains including language skills, attention and executive functions with 
verbal learning and memory being the most affected.(51) The decline in cognitive 
function has been associated with poor vocational outcomes, (52) impaired insight(54) 
and impaired basic sensory processing.(54) Sensory processing problems may impact on 
gross motor coordination and motor planning.(17) 
Emotive disturbances have been noted in terms of emotional expressions which may 
be decreased in range and intensity. These disturbances may give the impression of the 
patient being apathetic.(6) However, they experience difficulty linking emotion with goal 
directed behaviour due to prefrontal and cortical deficits. This would therefore affect 
volition, empathy and appropriate engagement in tasks. Research has indicated that a 
severe emotion perception deficit is associated with a poorer level of functioning and that 
poor identification of emotions of others impacts on satisfaction in social functioning.(55, 
56) 
2.8 Dual Diagnosis 
Commonly seen in practice is the co occurrence of a severe mental illness and a 
substance abuse disorder which is known as a dual diagnosis.(1) Dual diagnosis is 
associated with poorer clinical outcomes such as increase in psychotic symptoms, poorer 
treatment compliance, increased relapse rate, poor money management, increased 
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violence and increased hospitalization as compared to a single diagnosis of either a 
psychiatric or a substance abuse disorder. (1, 2) 
The neuropsychological deficits such as executive and memory disturbance, found 
with patients with a psychotic disorder have also been reported in patients presenting 
with alcohol use or substance use disorders.(57) Chronic use of alcohol and cannabis has 
been, for many decades, shown to cause cognitive impairments in adults.(21) Studies 
within the last 5 years, have indicated that amongst both healthy individuals and patients 
with schizophrenia, there appears to be little difference in cognitive performance 
between cannabis users and non-users. Patients diagnosed with schizophrenia and 
suffering from cannabis use disorder had poorer academic achievements and lower 
vocabulary scores, but performed better in tests of verbal and working memory, 
visuomotor speed and executive function than individuals diagnosed with just 
schizophrenia. This is therefore suggesting that cannabis use has only subtle effects on 
the neurocognitive performance (58, 59) and that co morbid alcohol or cannabis abuse or 
dependence has limited effects on cognitive performance in individuals already 
presenting with a psychotic disorder.(57) This better cognitive functioning in substance 
users may however be due to a lower vulnerability to psychosis, as compared to purely 
schizophrenic patients. (58) This association between better cognitive performance and 
cannabis use in schizophrenia may be driven by a subgroup of “neurocognitively less 
impaired” patients, who only developed psychosis after a relatively early initiation into 
cannabis use. (60) 
This recent literature has only been conducted in small study populations and 
therefore larger studies will still need to be conducted in order to make evidence based 
associations. 
2.9 Best Practice in Treatment of Substance Abuse and Dual 
Diagnosis 
Developing countries, such as South Africa, are particularly vulnerable to an increase 
in substance use because of the demands placed on the health care system, society and 
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the fragile economy. The lack of resources, poor facilities, poverty, unemployment and 
limited health services only compound the situation.(45)  
Substance abuse treatment programmes have therefore started to shift from the 
medical model of treating the individual’s symptoms once a problem has occurred, to the 
more psychosocial model of aiming to prevent the substance abuse problem from 
occurring, at the community level. This involves various strategies to educate young 
individuals and limit access to illegal and legal substances. There is a need for quality 
assessments, adolescent-specific treatment services, use of a variety of therapeutic 
modalities, evidence-based practice, and research.(48)  
Primary prevention strategies have focused on community intervention programmes 
for adolescents are aimed at raising community awareness about the harmful effects of 
substances, developing skills, providing social support and preventing substance abuse. 
(17) An example of a community intervention programme is the Health Wise programme 
which has been documented as being a promising approach to reducing multiple health 
risk behaviours among the population of school-going South African adolescents.(61) 
Targeting university student populations by implementing brief, motivational or skills-
based interventions, targeting high-risk students identified either through brief screening 
in health care centres or other campus settings or through membership an identified risk 
group, has also shown positive results in the literature. (62)  
Secondary preventions strategies for individuals with a substance abuse problem have 
focused on promoting attendance in community intervention programmes such as 
support groups. The SANCA Alcoholics Anonymous and Narcotics Anonymous support 
groups have shown to increase alcohol abstinence and reduce substance and alcohol 
problems. (63) 
Differences have been noted between alcohol and cannabis users in terms of their 
adherence and compliance to treatment programmes. Those who were cannabis-
dependent were less likely to begin treatment than those dependent only on alcohol. 
Clinicians may therefore consider additional efforts during the admission process to 
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engage individuals who abuse cannabis and have decreased motivation. (64) A high 
motivation to change is a crucial triggering factor to individuals’ engagement in clinical 
treatment.(65) Motivational interviewing has shown to be a beneficial counselling tool 
when addressing individuals who abuse substances as it facilitates their own motivation 
to change and increases their level of insight.(66) 
The treatment of individuals who present with a dual diagnosis has been conflicting 
due to the separation of medical and rehabilitation services. These approaches conflict in 
methodology and thus have proven to be ineffective. The combination of psychosocial 
and pharmacological interventions has shown to have the most beneficial outcomes in 
treating dual diagnosis. Multidisciplinary interventions that use a cognitive behavioural 
approach or cognitive training as well as the involvement of people close to the abuser, as 
well as some of the specific pharmacological interventions, have been shown to yield the 
best results in terms of indicators of abstinence, prevention of relapse and improve 
cognitive performance, symptoms and everyday functioning.(67-69) Psychosocial 
interventions have been shown to reduce the rate of relapse and enhance activity 
participation .The main focus of these interventions include, optimizing function, 
minimize risk of relapse, improve quality of life, and minimize hospitalization.(70) Some 
examples of these interventions include motivational interviewing, psycho education and 
occupational therapy. 
Psycho education refers to the education offered to people who live with a 
psychological disturbance. Psycho educational programmes are one of the main forms of 
intervention in improving knowledge in patients suffering from Schizophrenia in order to 
facilitate compliance, prevent relapse and improve overall well being. Some of the main 
goals of a psycho education programme include providing applicable information, 
facilitating the expression of feelings, including family members to discuss their feelings 
and concerns, identifying stressful factors and coping behaviors and providing the family 
and the client with tools to develop a balance and sense of wellbeing in their daily 
lives.(71) These programmes also diminish stigmatization, alter negative perceptions and 
attitudes as well as decrease the health care costs and the number of relapses.(72) 
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Research has shown that engagement in an occupational therapy programme 
enhances vocational, social and a variety of other occupational outcomes.(73, 74) 
Participation in highly structured leisure activities has also shown to reduce the levels of 
destructive social behaviour, reduce the occurrence of substance and alcohol abuse and 
improve activity participation in all daily life tasks.(75) 
The focus of intervention for dual diagnosis is ensuring abstinence from the substance 
by changing behaviour and improving the individual’s lifestyle. This has been shown to be 
the most successful where a multidisciplinary approach has been used as well as through 
the combination of both psychosocial and pharmacological interventions. (17) 
2.10 Conclusion 
Statistics have provided some insight into the depth and ever increasing abuse of 
substances within the South African population. The literature presented some possible 
risk factors that lead to substance abuse and the impact substances can have on normal 
adolescent development. Cannabis and alcohol abuse have been discussed and the 
impact that they have on activity participation. These substances have been shown to 
cause multiple levels of impairment, a variety of negative social and occupational 
consequences and being linked to dual diagnosis. The guidelines for treatment for 
individuals with a dual diagnosis are focused on integrating services between mental 
health and social substance abuse programmes. Currently these treatment guidelines are 
limited and non specific in terms of type of psychiatric diagnosis and type of substance. 
This results in these individuals developing poorer clinical and functional outcomes. (1, 
48)  
Through this research, the first stage in attempting to address this problem is to 
determine the exact impact or effects of the different substances in individuals already 
diagnosed with a psychiatric disorder. This will be further discussed in the chapters to 
follow. Once a thorough assessment and baseline level of function is determined for each 
substance and diagnosis, the treatment and psychosocial programmes can be tailored to 
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address specific problems. This may lead to better long term outcomes such as sustained 







CHAPTER 3  Methodology  
 
3.1 Introduction 
This chapter will describe how the study was executed, the population that was 
accessed and procedures that were followed including how the data was collected and 
analyzed. 
3.2 Research Design 
A non-experimental design and observational study (cross section) with no 
intervention was used to achieve the aims and objectives of the study. This research 
design was selected as it provided a quick, non invasive and inexpensive once off 
assessment procedure for data collection.  The process involved a once off occupational 
therapy assessment using the Activity Participation Outcome Measure (APOM) (Appendix 
A,) as the recording tool, of participants who met the specific inclusion and exclusion 
criteria. The information obtained produced descriptive quantitative data which was 
analyzed accordingly. 
3.3 Population  
Individuals with a confirmed diagnosis of an Axis 1 Psychotic disorder were the 
population investigated in this study. The population consisted of three groups: 
 Group 1: Psychotic Disorder with cannabis abuse/dependence 
 Group 2: Psychotic Disorder with alcohol abuse/dependence 
 Group 3: Psychotic Disorder with no substance abuse/dependence 
Alcohol and cannabis have been shown to be the most common substances of abuse 
amongst the South African population (15) and therefore these substances were selected 
and grouped separately in order to determine their effects on the level of activity 
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participation. The grouping of the participants into three groups allowed the researcher 
to determine the impact of adolescence initiated alcohol and cannabis use on the level of 
activity participation whilst utilizing the no substance group as a comparative variable for 
the level of activity participation in individuals presenting with a psychotic disorder. This 
allowed the researcher to determine the variances on the level of activity participation 
caused either by the alcohol or the cannabis. 
3.4 Sample 
3.4.1 Sample Selection 
The sample that was selected included individuals attending outpatient and inpatient 
services at CHBAH. Individuals who utilized services at South African National Council on 
Alcoholism & Drug Dependence (SANCA) Soweto were also approached.  However, none 
of the participants at SANCA Soweto met the inclusion and exclusion criteria and 
therefore only participants from CBHAH were included. The method of sampling was 
purposeful and convenient as the researcher accessed those individuals who were 
already utilizing hospital resources. The purposeful and convenient sampling was directed 
only at those individuals who met the inclusion criteria. Participants were referred to 
occupational therapy but participation in the research study was on a voluntary basis 
after being provided with information concerning the study and signing a consent form. 
3.4.2 Sample Size 
The size of the sample was determined according to the number of domains in the 
APOM (Appendix A). An estimated size of 3-4 subjects per domain was used to calculate a 
meaningful difference between the groups. With eight domains in the APOM, the 
estimated ideal sample size was determined at 24 – 32 participants per group.  The 
sample size calculator designed by Gertsman was used to calculate the value at which 
statistical difference could be determined. This is a statistical software package with a 
sample size calculator and freely available from www.sjsu.edu/faculty/gerstman/EpiInfo/bin-
case.htm .  The power was set at 95%, the standard deviation at three and the mean effect 
difference at three.  The calculation was therefore as follows: 
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16 x 32 = 144/32  
144/9 = 16.   
From this caluculation, a  minimum 16 participants was needed per sample group. A 
total sample size of 16-30 was therefore accepted for each sample group however the 
researcher decided to set an ideal sample size at 30 participants, in order to promote 
more reliable and valuable data.  
3.4.3 Criteria applicable to all participants 
3.4.3.1  Inclusion Criteria 
Criteria were used in order to obtain a sample which was mostly consistent and 
eliminated as many confounding variables as possible. The inclusion criteria included: 
 Only male participants were used in the study as psychotic disorders with co 
morbid substance abuse or dependence had been shown to be more prevalent 
amongst the male population. (76) 
 The participants were between the ages of 19 -29 years. This age band was 
selected as according to various theorists such as Piaget and Erikson these 
early adulthood years are the years when cognition, motor, perceptual and 
social skills are fully developed and therefore the individuals should be able to 
achieve a high level  of functioning. 





3.4.3.2  Exclusion Criteria 
 
Criteria were used in order to exclude certain individuals from participating in the 
study in order to eliminate variables which may affect the level of activity participation. 
The exclusion criteria were as follows: 
 Participants were not actively psychotic or under the influence of any psychoactive 
substances or alcohol at the time of consent and assessment. 
 The participants did not have an additional medical diagnosis which severely 
influenced their level of function. 
 The participants were not diagnosed with any other psychiatric axis 1 or 2 
disorders. (i.e. other than a psychotic disorder) 
3.4.4 Criteria specific for Group1: Cannabis abuse/dependence and    
Group 2: Alcohol abuse/dependence 
3.4.4.1  Inclusion Criteria 
 The initiation of the alcohol or cannabis use took place between the ages of 
12-18 years which was determined by the personal interview with the 
participant and collateral information from the participant’s family members.  
 The participants met the criteria for either cannabis or alcohol abuse or 
dependence according to the DSM-IV, at some point between their age of 




3.4.4.2 Exclusion Criteria 
 The participants have met the criteria for abuse of or dependence on any 
other substance (i.e. other than alcohol or cannabis). 
 The participants met the criteria for abuse or dependence for both alcohol and 
cannabis simultaneously. 
3.4.5 Criteria specific for group 3: No alcohol or cannabis abuse/ 
dependence 
 
3.4.5.1  Inclusion Criteria 
 The participants did not meet the criteria for either substance or alcohol abuse 
or dependence. 
3.5 Measurement Tools 
An occupation based assessment process was used to assess each of the participant’s 
level of activity participation. This process involved an initial interview of the participant, 
followed by the participant engaging in a variety of structured activities, both individually 
and within groups, to assess each of the occupational performance areas. Some examples 
of the activities included soccer, beading, painting, paper based crafts, cooking, sewing, 
ironing, gardening, etc. An interview with the family was also conducted in order to gain 
any additional collateral information required. The assessments will be discussed in more 
detail under data collection. 
The Montreal Cognitive Assessment (MOCA) (Appendix B) tool was also administrated 
at this stage. The MOCA is a bed side screening tool to assess an individual’s cognitive 
abilities. The tool was developed and norm referenced on an American population. It 
includes components of cognition such as visuospatial abilities, attention, language, 
mathematics, memory, sequencing and orientation. The total score for the test is 30 with 
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an expected value of 26 or higher to be of normal cognitive abilities. This tool was 
selected as currently within the research setting the Mini Mental Status Examination, 
another type of bed side cognitive screening tool, is being used by the unit psychiatrist. 
The test re-test reliability of the Mini Mental Status Examination is poor and no evidence 
on its construct validity could be found, therefore another cognitive screening tool had to 
be selected. The MOCA was selected as literature indicated that it is s a useful tool in 
detecting mild dementia and Alzheimer’s dementia with a fairly good reliability and 
validity.  (77, 78) This tool was used to assist the researcher with levelling the client on 
the APOM (Appendix A) in terms of their process skills. 
The MOCA (Appendix B), structured activities and interview provided the researcher 
with sufficient information in order to determine the client’s level of activity participation. 
The APOM’s (Appendix A) computer based software program was then used to record 
the participant’s overall level of activity participation. This outcome measure was selected 
as it is allows the researcher to record most aspects of the individual’s level of activity 
participation. The APOM records eight different domains of activity participation 
including motivation, self esteem, process skills, life skills, affect, balanced lifestyle, role 
performance and communication skills. The outcome measure was developed and 
researched in South Africa and therefore the results produced are viewed as being valid 
and reliable within the South African context. The inter-rater and intra-rater reliability has 
shown correlations of 0.7 and above and the construct validity was support through the 
Rasch analysis revealing that the scale of the APOM can indeed be transformed to an 
interval scale, thus creating a true measure of activity participation. The APOM has been 
proven as an effective tool to detect change, the scores allow for accurate analyses as 
well as the ability to determine a significant difference on the level of activity 
participation between the three groups. (79) 
The APOM (Appendix A) scores range from one to eighteen with one being the lowest 
level of activity participation and eighteen being the typically highest level of activity 
participation seen in the clinical setting. Clinical experience has shown that at CHBAH, the 
average score range for the psychiatric population is between seven and eight and a 
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patient on a level nine or ten is typically then discharged from the hospital setting. On a 
level seven or eight the patient typically presents with fluctuating moods, unrealistic self 
concept, egocentric interpersonal relationships, depends on others to structure and 
support participation in an activity, able to perform basic hygiene tasks but is reliant on 
others to complete household chores, financial management duties and accessing 
transport. On a level ten the patients mood is more stable, they have better control of 
their emotions, realistic self concept but lack confidence or self esteem, are able to 
complete familiar tasks but needs support in completing unfamiliar tasks, independent in 
hygiene and some grooming tasks, able to complete some household chores 
independently but has difficulties with financial management and child care duties. (79) 
Although the APOM (Appendix A) has been determined as a valid and reliable tool and 
the researcher bias was also controlled by the researcher completing the assessment on 
all the participants across all three groups, the researcher opted to include an additional 
procedure during data collection to limit subjectivity and bias. This involved the 
assessment of one random participant per group, conducted on site by another 
occupational therapist qualified in using the APOM. The other occupational therapist and 
the researcher both completed an assessment on the same participant and documented 
the APOM scores. The APOM scores for the one participant were then compared and 
discussed. The outcome of this procedure showed good agreement of APOM scores 
which enhanced the quality of the data.  
3.6 Data Collection 
Once the researcher had identified a possible participant, the unit psychiatrist was 
approached and the inclusion/exclusion criteria further discussed.  A referral to the study 
was then completed by the unit psychiatrist (Appendix C). The unit psychiatrist was 
responsible for confirming the psychiatric diagnosis as indicated in the hospital file. Since 
the diagnosis was one of the major inclusion criteria for the study, it was important to 
work with confirmed diagnoses. The medical history was obtained from the hospital file in 
order to determine the presence of any other medical conditions which would have 
excluded the participant from the study. The unit psychiatrist determined the 
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participant’s ability to engage in the study in terms of being psychiatrically stable and 
being able to provide informed consent. 
The DSM-IV criteria on substance abuse and dependence was used in order to 
categorise participants and also exclude other participants who did not meet that specific 
criteria from the study. The level of substance use was categorised by the unit 
psychiatrist.  
Once the unit psychiatrist had completed the referral form for the study (Appendix C), 
the researcher then commenced with the data collection process and the participant 
engaged in a full occupational therapy assessment to determine his level of activity 
participation.  
The researcher developed a classification of group data sheet (Appendix D) which was 
used to record each participant’s necessary details including type of psychotic disorder, 
type of substance abuse, age initiated substances, current age and level of substance 
abuse. The participant demographic information sheet was completed by the researcher 
in order to record the participant’s basic background information including address, 
contact details, personal history, occupational history, family history and medication. This 
information was all obtained from the initial interview with the participant, which had a 
duration of approximately one hour.  
Once the initial interview was completed and all background information had been 
obtained, the researcher and the participant then engaged in a variety of different 
structured activities. The activities selected were dependant on the participant in terms 
of his history, culture, age, gender, etc. Some example of activities used included soccer, 
cooking, gardening, painting and paper based crafts. This process of selecting activities 
based on the individual follows the philosophy and fundamental values of occupational 
therapy. The assessment would therefore need to be client centred in order to accurately 
reflect the person’s functioning in all of the occupational performance areas. (11) One 
standard activity or group could therefore not be selected, as it may not be within all the 
participants frame of reference, interest or roles and thus would be an inaccurate 
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assessment or reflection of their level of occupational performance. The activities 
facilitated the researcher in levelling the participant’s life skills, process skills, affect, 
motivation, self esteem, role performance, communication/interaction skills and 
balanced lifestyle. 
The participants generally engaged in one assessment, however, the duration of the 
assessment was approximately 3 hours and therefore some participant’s who were of a 
lower level of functioning found it difficult to sustain their participation for this length of 
time. This resulted in certain participants returning for a second session in order to 
complete the assessment. 
Once the researcher had completed the assessment, the information was transcribed 
into the APOM programme, using numerical values to level the participant’s activity 
participation within the eight domains. The APOM then produced a composite score for 
the participant’s overall level of activity participation and it automatically generated a 
report and the results were displayed in a spider graph (Appendix A). The overall total 
score as well as the total score for each domain was recorded onto an Excel spread sheet 
against the participants current age, type of substance, age initiated substance use, level 
of substance abuse and type of diagnosis. 
All of the participants in the study informed the researcher that they were able to 
understand and read English. The researcher determined that it was acceptable then to 
provide the participants with informed consent forms in English. Some participants 
requested if they were able to ask questions or respond to the researcher in their home 
language and for these participants a translator was necessary. An occupational therapy 
technician was used as a translator to explain the information sheet, facilitate the process 
of informed consent (Appendix E), assist obtaining certain demographic information, 
explain the procedure for each activity as well as ask questions which had been directed 
by the researcher, in order to determine the participant’s state of mind and processing 
skills whilst completing each activity. The translator was informed to translate only exact 
words and phrases used by both the researcher and the participant. This minimised the 
translator’s subjectivity and bias within the study. 
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3.7 Data Analysis 
The data recorded on the excel spread sheet was analyzed within and between the 
three groups in order to produce descriptive and inferential statistics. The descriptive 
data produced was analyzed in terms of the number of participants per group, age 
initiated substances, current age of participants and their APOM scores. The median, 
interquartile range, frequency and percentages of this data were calculated. The median 
and interquartile range were used to provide the researcher with a clearer understanding 
of the middle values concerning participants current ages and ages initiated substances. 
Within the sample, two or three participants presented with extreme values and these 
would have adjusted the mean towards the extreme values, rather than being a true 
representation of the middle values within the sample. This data has been drawn up into 
different tables, bar graphs and box plots in order to be easily accessible analyzed. 
In terms of calculating the inferential statistics, the Bartlett’s test was used to test for 
equal variances, while the Bonferroni test was used to adjust for multiple comparisons. 
The Bartlett’s test permits one to compare the variance in two or more sample groups to 
determine if they are drawn from populations with equal variance, in other words, to test 
for homogeneity. 
The ANOVA, a test to analyze the variance between groups, assumes that there are 
equal variances between groups. The ANOVA was done after the Bartlett’s test had 
indicated that the groups had equal variance.  Using the means of the three groups in the 
study, the ANOVA tested the null hypothesis whether the population mean of the total 
APOM score is equal across all three groups. The statistical significance was set at p<0.05. 
ANOVA was also applied to test for differences between each domain across the three 
groups. The greatest difference between groups was noted. 
3.8 Ethics 
Ethical clearance was obtained from the Human Ethics Research Committee of the 
University of the Witwatersrand before the commencement of the study. Ethical 
clearance number M120501 (Appendix F). 
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Permission and approval was obtained from the Ethics Research Committee at Chris 
Hani Baragwanath Academic Hospital before the data collection process was able to be 
commenced at this hospital (Appendix G).  
All participants were provided with the information sheet and signed informed 
consent before commencing with the research (Appendix E). If the participants did 
present with psychotic symptoms, these symptoms did not impact on their ability to give 
informed consent to the study before commencing with the occupational therapy 
assessment. All participants were not objectively under the influence of substances by 
withdrawals or intoxication symptoms, at the time of the assessment. All participants 
were cognitively able to understand the purpose of the research study and provide 
informed consent. 
All participants engaged in the research on a voluntary basis and none of the 
participants requested to leave the study.  
3.9 Conclusion 
The above chapter described how the study was executed and what procedures were 
followed. It describes the design, sample, measurements, process, tools and the analysis 











CHAPTER 4  Results 
 
4.1 Introduction 
This chapter commences with the descriptive analysis of the data followed by 
inferential statistics. Tables, bar graphs and box plots are used to present the descriptive 
statistics. The results of the inferential statistics are depicted in table form. 
4.2 Descriptive Statistics 
The data presented below describes the study sample as well as the scores obtained 
from the APOM and MOCA. 
Table 4.1: Represents the median and the interquartile range (IQR) of the 
chronological age, the APOM and MOCA scores across all 3 groups. The age of onset of 
the substance use (age started) are presented for Group 1 and 2. 
From this data, various observations and trends have been identified. Individuals 
abusing cannabis presented with the lowest IQR score for their current age compared to 
the other 2 groups. This indicates that individuals abusing cannabis presented to this 
study as currently having the youngest age compared to the alcohol group which 
presented as being the oldest participants utilizing psychiatric services at CHBAH. Those 
individuals who abuse cannabis commenced their use of cannabis at a younger age (15 – 
16 years) as compared to those abusing alcohol. The cannabis group had a narrower IQR 







Table4.1: Median (interquartile range) across all 3 Groups 
 
The sample size at the end of the research included 30 participants in the cannabis 
and no substance abuse groups, with a total of 18 participnats in the alcohol group. 
Overall the total sample size included 78 participants.  
When comparing the average APOM scores for each domain across the three groups, 
the highest level of activity participation was noted in the alcohol group and participants 
 Group 1 
(n = 30) 
Cannabis 
Group 2 
(n = 18) 
Alcohol 
Group 3 
















(21 – 26) 
28 
(24 – 29) 
27 
(23 – 29) 
25 
(22 – 28) 
 
Age Started Substances 
15 
(15 – 16) 
16.5 
(15 – 18) 
n/a 16 









(7.7 – 10.7) 
10.2 
(9 – 12.3) 
7.7 
(6  - 8.7) 
9 
(6.7 – 10.3) 
Balanced Lifestyle 7 
(6 – 9) 
9 
(7.3 – 9.7) 
7.3 
(6.3 – 8.3) 
7.5 




(7.5 – 10.5) 
10.6 
(8.2 – 12.2) 
7.25 
(6.2 – 8.2) 
8.2 
(6.8 – 10.5) 
Life skills 8.4 
(6.8 – 10) 
9.9 
(9.3 – 11.2) 
6.8 
(6.2 – 7.7) 
7.6 
(6.7 – 9.8) 
Motivation 7.8 
(6.8 – 9.8) 
9.4 
(8.4 – 10.6) 
6.8 
(6.6 – 7.8) 
7.6 
(6.8 – 9.8) 
Process Skills 9.2 
(7.1 – 11) 
10.2 
(9.6 – 11.6) 
7.5 
(6.6 – 8.6) 
8.6 
(7.1 – 10.5) 
Role Performance 8 
(7.5 – 10.5) 
10.6 
(9.6 – 11.6) 
7.6 
(6.6 – 8.2) 
8 
(7.5 – 10.5) 
Self Esteem 7.7 
(6.9 – 10.7) 
10.6 
(8.4 – 11.4) 
7.6 
(6.4 – 8.4) 
7.9 




(16 – 24) 
20 
(15 – 25) 
19 
(15 – 22) 
20 






















Current Age of Participants
within the group of no substance abuse scored the lowest across all of the domains. The 
only exception hereto is in the balanced lifestyle domain where the average APOM scores 
were similar across all groups.  The actual scores range between six and nine and 
according to the APOM descriptions of these scores, the participants are unable to 
organize a meaningful and satisfying routine with inappropriate habits (e.g. substance 
and alcohol abuse or dependency) that dominate their life style.  
Unlike the APOM scores, the scores depicted by the MOCA were similar across all 
three groups. This is noticeable below the “normal” score of 26 or higher. This indicates a 
low level of cognitive functions for example memory, sequencing, orientation, etc, as 









Figure 4.1: Box plot depicting the median and IQR of participant’s 






















Figure 4.1 diagrammatically represents what is indicated in Table 4.1.  Participants 
within the cannabis group were generally of a younger age whereas the participants 
within the alcohol group were the oldest. Individuals within the no substance abuse group 
identified with the widest range of current age. 
 
Figure 4.2: Box plot depicting the median and IQR for the age 
participants initiated substance abuse 
 
Figure 4.2 represents the data presented in Table 4.1. The data from the sample 
indicates that the participants within the cannabis group started abusing substances at a 
younger age as compared to the alcohol group. It should however be noted that within 




Figure 4.3: Comparing average APOM scores across the three groups 
 
Figure 4.3 represents the average APOM scores across all three groups for all eight 
domains. Figure 4.3 graphically represents the information presented in Table 4.1. It 
shows that across all of the domains the no substance group consistently scored the 










Table 4.2: Abuse versus Dependence in Group 1 and 2 
  Group 1  
(n = 30)  
Cannabis 
Group 2  
(n = 18)     
Alcohol 
Total 
 (n = 48) 
Total 
Percentage 
Abuse Frequency 26 17 43 89.6 
Percentage 54.2 35.4 89.6 
Dependence Frequency 4 1 5 10.4 
Percentage 8.3 2 10.4 
 
Table 4.2 Compares the number of participants diagnosed with either abuse or 
dependence in the cannabis and alcohol groups. More participants overall were 
diagnosed with abuse but those diagnosed with dependence mostly originated from the 
cannabis group. 
Table 4.3: Type of Diagnosis 
  Group 1  
(n = 30)  
Cannabis 
Group 2  
(n = 18)     
Alcohol 
Group 3 










Frequency 17 15 0 32 41 
Percentage 21.8 19.2 0 41 
Schizophrenia Frequency 13 3 30 46 59 
Percentage 16.7 3.8 38.5 59 
 
Table 4.3 Tabulates the different types of diagnoses between the 3 groups. Only two 
diagnoses were present in the sample population and those included Schizophrenia and 
Substance Induced Psychosis. The most common diagnosis across the whole population 
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was that of schizophrenia but substance induced psychosis was more predominant within 
the alcohol group. 
 
 Figure 4.4: Comparison of participant’s total APOM scores against 
age initiated substances 
 
Figure 4.4 shows the age participants started to abuse either cannabis or alcohol 
against the level of their APOM scores.  The graph indicates that individuals who started 
abusing substances at a younger age have lower APOM scores. A Pearson correlation 








Figure 4.5: Comparison of participants APOM scores against their 
diagnosis 
 
Figure 4.5 displays the APOM scores between the two different diagnoses present 
within the sample. It can be noted that the participants diagnosed with substance 







Figure 4.6: Comparison of total APOM Scores against their diagnosis 
and group 
Figure 4.6 displays the total APOM scores from each of the two diagnoses present in 
the sample including schizophrenia (SZP) and substance induced psychosis (SIP). The 
APOM scores are then compared between the three groups. It is noted that participants 
diagnosed with schizophrenia had a lower level of activity participation across all three 
groups. 
4.3 Hypothesis Testing  
The null hypothesis was that the population mean of the total APOM scores is equal 
across all three groups.   
The null hypothesis stated that there would be no impact of alcohol and cannabis on 
the level of activity participation. The null hypothesis was rejected with a significant p 
value at 0.0001 as calculated with ANOVA.  This indicates that there is a statistically 
significant difference between the total APOM score across three groups indicating that 
alcohol and cannabis did have an affect on the level of activity participation. It should be 
noted that the differences were highly significant between the alcohol and the no 
substance group (p<0.000), significant between cannabis and no substance group 
(p<0.022) but no significant difference between the alcohol and cannabis groups 
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(p<0.075). A highly significant statistical difference was noted in seven of the eight 
domains with p-values less than 0.0001. Balanced lifestyle was the only domain with a p-




















Table 4.4: P-Values when comparing APOM and MOCA Scores across all Three 
Groups 
 
Significance set at p< 0.05*, p< 0.01**, p<0.001*** 
APOM P-Value (ANOVA) 
 p-value when comparing 
APOM Scores across all 3 
groups 
p-value in a two-by-two table to indicate the variance 
between the groups 
Total APOM Score 0.0001***  Cannabis Alcohol 
Alcohol 0.075 - 
No Substances 0.022* 0.000*** 
Affect 0.0001***  Cannabis Alcohol 
Alcohol 0.357 - 
No Substances 0.007** 0.000*** 
Balanced Lifestyle 0.0368*  Cannabis Alcohol 
Alcohol 0.054 - 
No Substances 1.000 0.070 
Communication/ 
Interaction Skills 
0.0000***  Cannabis Alcohol 
Alcohol 0.108 - 
No Substances 0.002** 0.000*** 
Life skills 0.0000***  Cannabis Alcohol 
Alcohol 0.061 - 
No Substances 0.023* 0.000*** 
Motivation 0.0004***  Cannabis Alcohol 
Alcohol 0.144 - 
No Substances 0.050* 0.000*** 
Process Skills 0.0002***  Cannabis Alcohol 
Alcohol 0.188 - 
No Substances 0.023* 0.000*** 
Role Performance 0.0000***  Cannabis Alcohol 
Alcohol 0.032* - 
No Substances 0.045* 0.000*** 
Self Esteem 0.0005***  Cannabis Alcohol 
Alcohol 0.026* - 
No Substances 0.314 0.000*** 
 p-value when 
comparing MOCA Scores 
across all 3 groups 
p-value in a two-by-two table to indicate the variance 
between the groups 










*All of the above values passed the Bartlett's test for equal variances 
The ANOVA test was applied to determine statistical difference and the Bonferroni 
test of multiple comparisons was used to account for the variances. 
4.4 Conclusion 
The above chapter describes both the descriptive and the inferential statistics for the 
study. Certain trends and themes have been highlighted which will be further discussed in 
















CHAPTER 5  Discussion 
 
5.1 Introduction 
A negative impact on the level of activity participation was duly noted in the results 
detailed in the previous chapter. This chapter shall discuss the previously put forward 
results and what noticeable factors appear to have contributed towards the level of 
activity participation. 
5.2 Decreased Prevalence of Alcohol Abuse in Study  
A total of seventy eight participants were included in the sample for this study. Thirty 
participants were placed within the cannabis and no substance abuse groups with only 
eighteen identified as being within the alcohol group. The decreased number of alcohol 
participants can be attributed to various factors observed by the researcher during the 
data collection process. According to the referring psychiatrists some alcohol users 
presented with a mood disorder and therefore had to be excluded from the study. A 
strong association between substance use with mood and anxiety disorders has also been 
noted in the literature and this was observed in clinical practice.(80) Most participants 
indicated that cannabis was cheaper and more easily accessible than alcohol and 
therefore they used cannabis more frequently. This is a development noted in recent 
literature as within the South African context the taxes placed on alcohol are increasing, 
causing cannabis to be more accessible than alcohol.(81) Participants indicated that 
within the particular age group selected for the study (19 – 29 years), it was seen as being 
culturally acceptable to use cannabis compared to drinking alcohol which was seen to be 
more acceptable in a person older than thirty years of age. These factors appeared to 
have contributed to more participants meeting the criteria for the cannabis group as 
compared to the alcohol group. This reduced the amount of data available from the 
alcohol group but the results still produced valuable statistically significant differences 
which were analyzed and particular trends noted.  
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5.3 Adolescent Initiation of Substances  
Participants in the cannabis group typically started abusing cannabis at an earlier age 
as compared to the alcohol group. For those participants using cannabis, the average age 
of onset was less than sixteen years of age and therefore towards the middle of high 
school. There were, however some extreme values from the data which indicated that 
some participants started using cannabis as young as twelve years of age. This can be 
attributed to the previously put forward factor of cannabis being cheaper and more easily 
accessible than alcohol as well as increased peer pressure to use cannabis. This confirms 
the previously noted trend of wide spread and increased use of cannabis amongst the 
Soweto population.(81)  
During adolescence an individual is typically still developing his or her cognitive, 
social, emotional and occupational skills. It has been indicated that certain cognitive and 
emotional skills are only fully developed by the age of 24 years including abstract 
reasoning (82). The age when participants in the cannabis and alcohol group started 
abusing the substance was correlated against the overall APOM scores. It was noted that 
participants who started using cannabis or alcohol at a younger age typically had a lower 
APOM score. This suggests that adolescence initiated substance abuse does have a 
negative impact on an individual’s level of activity participation. The earlier a person 
initiates the substance, the greater the number and severity of developing adolescent 
skills are affected and therefore, the poorer are occupational outcomes in adulthood.(21) 
5.4 Current Ages of Participants  
In this study sample, the participants within the cannabis group were at the time of 
assessment of a younger age compared to those in the alcohol group. This indicates that 
within the sample, the cannabis users met the criteria for abuse or dependence at a much 
younger age compared to alcohol users. Meeting the criteria for substance abuse or 
dependence at a younger age appears to have contributed towards the cannabis group 
having a lower level of activity participation compared to the alcohol group. This confirms 
what had been documented in previous research that earlier age of onset and increased 
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severity of use of cannabis does negatively impact on an individual’s level of occupational 
performance.(21,37, 38) 
Participants within the no substance group displayed the widest range of their current 
age indicating that schizophrenia is prevalent throughout the age band selected and that 
early adulthood is the expected norm, according to the DSM-IV, for the onset of 
schizophrenia.(6) 
5.5 Substance Abuse versus Substance Dependence 
Within the study sample, the majority of the participants were classified as having 
substance abuse as compared to substance dependence. This correlates with literature as 
substance dependence is described as the more harmful and debilitating substance use 
disorder compared to abuse and therefore fewer participants would be assumed to have 
a dependence diagnosis. (6) It should, however, be noted that this data should be 
interpreted with caution as during the data collection process it was observed that some 
of the participants did meet the criteria for substance dependence, according to the 
researcher, but were not classified accordingly on the DSM-IV by the referring 
psychiatrist. It can be inferred that the interpretation of the criteria between substance 
abuse and dependence lends itself to subjectivity and therefore makes the distinction 
between the two levels difficult. Cannabis withdrawal symptoms are also non specific and 
therefore difficult to identify whether they meet the criteria for dependence. Within the 
acute setting the distinction between abuse and dependence does not overtly change the 
initial management of the individual and therefore owing to time constraints and high 
patient numbers, this particular distinction does not impact on immediate medical 
management. The distinction, however, did facilitate the understanding of the degree of 
impact on the individual’s level of functioning. This subjectivity and discrepancy has been 
corrected with the recent edition of DSM where within the DSM-5 the criterion for 
substance abuse and dependence has combined into one diagnosis. The distinction 
between abuse and dependence is no longer made and individuals are classified together 
as having a substance use disorder. (14) 
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The participants within the study who were diagnosed with substance dependence 
mostly fell into the cannabis group. This can be assumed to be due to the previously 
discussed factors of the easier accessibility of cannabis and earlier age of initiation of 
cannabis.(81) It also correlates to the lower level of activity participation noted in the 
cannabis group compared to the alcohol group as a participant meeting the criteria for 
substance dependence according to the DSM-IV should experience more disruption and 
deterioration in their occupational functioning. (6) 
5.6 Level of Activity Participation 
A statistically significant difference was found between the three groups across all of 
the APOM scores. The clinical significance of this is that firstly, the alcohol group 
consistently presented with a higher level of activity participation across all eight of the 
APOM domains. This indicates a better performance in life skills, communication, affect, 
motivation, balanced lifestyle, self esteem, role performance and process skills compared 
to the cannabis and no substance abuse group. From this data, it can be inferred that 
alcohol does have a negative impact on occupational performance as the APOM scores 
for this group were below the expected norm for an adult population however the impact 
is not as severe on the level of activity participation as compared to cannabis. This 
correlates with research indicating that cannabis does cause severe neurocognitive 
changes in the brain which negatively impact on an individual’s functioning. (40, 41) 
Balanced life style was the only domain that was not significantly different between 
the three groups, indicating that all three groups experienced problems in this domain. 
This came as an expected result as lifestyle problems are often reported in literature as 
the causative factors for substance abuse and a possible precursor to mental illness.(83) 
5.7 Comparison of APOM Domains 
The differences between the eight APOM domains were analyzed and compared 
between all three groups. 
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 Motivation was severely impacted across all the groups but mostly affected the no 
substance abuse group. All of these participants were diagnosed with schizophrenia and 
this finding is therefore in agreement with the DSM-IV criteria for schizophrenia, 
indicating amotivation as a clinical symptom of this diagnosis. (6, 43) This lack of 
motivation and drive demonstrated as being one of the founding causal factors to the 
deterioration in activities of daily living and higher order life skills. Decreased motivation 
within the other two groups also had a negative impact on the individual’s level of 
performance skills and may further hinder the individual’s ability to engage in other 
constructive activities such as work or studies even in the absence of using substances. 
Self esteem was noted as being a poorer performing domain specifically within the 
cannabis group. This demonstrates the individual’s possible vulnerability to initially 
succumbing to peer pressure and using substances, as well as the reduced ability to 
abstain from cannabis as the individual may feel that he needs cannabis in order to feel 
good about himself. This therefore has implications towards the initiation and the ability 
to abstain from substances. Diminished self esteem and reliance on substances to 
compensate may negatively impact on the individual’s motivation and being able to 
realistic evaluate and set into motion goals or plans for the future.   
Process skills, although higher in the alcohol group compared to the other two groups, 
were in the lower half of the average domain scores. These are the cognitive abilities and 
work performance skills needed to execute any work task. This demonstrates a decline in 
certain cognitive functions within the alcohol group including aspects such as 
concentration, adaptation and concept formation. This is congruent with the literature 
determining that there is an association with alcohol use and cognitive decline (84). The 
no substance abuse group scored the lowest on the process skills domain when compared 
to the other two groups. This indicates that psychotic disorders have a severe impact on 
an individual’s cognitive functioning and this is directly linked to poor work performance. 
A decline in these skills may also hinder the therapeutic process as the individual’s 
learning abilities are negatively affected. This hinders the individual from understanding 
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the therapeutic process and being able to improve or adapt his lifestyle in order to 
improve occupational performance.  
The life skills domain incorporates components such as grooming, budgeting, conflict 
management, stress management, vocational skills, assertiveness, parenting, safety, 
problem solving, use of transport and taking care of your medication. A decline in these 
skills was noted across all three groups but more severely within the no substance abuse 
group. The life skills of stress management, care of medication and vocational skills were 
the most affected in this group. This directly contributes to the numerous relapses due to 
the defaulting of medication and poor constructive use of time, which is noted in the 
clinical setting for this population. Poor cognitive functioning and decreased motivation 
reduced the participant’s ability to perform and complete these skills independently. Poor 
performance in these skills also contributes to a decline in role performance and balanced 
lifestyle.  
Communication and interaction skills were the strongest domain within the alcohol 
group but the second lowest scoring domain in the no substance abuse group. This is 
linked to the no substance abuse group having a predominant diagnosis of schizophrenia. 
Individual’s diagnosed with schizophrenia typically present with a blunted affect, 
decrease emotional expression and psychomotor retardation. (6) These symptoms 
directly impact on the individual’s social skills and ability to communicate with others and 
express their views or opinions.  
5.8 Prevalence of Type of Psychotic Disorder 
Within the sample only two types of psychotic disorders were present that of 
substance induced psychosis and schizophrenia. This is expected within the sample size of 
the study as other psychotic disorders are relatively rare and not often seen in practice. 
(6) Within the no substance abuse group only the diagnosis of schizophrenia was present 
within the sample. The majority of the participants diagnosed with substance induced 
psychosis were found within the alcohol group as compared to an almost even divide 
between substance induced psychosis and schizophrenia within the cannabis group. This 
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is congruent with the literature that indicates that cannabis use may be a precursor to the 
development of schizophrenia and thus it is more predominant in the cannabis group 
(85). It has also been documented that alcoholism has been linked to co morbid mental 
disorders; however, cannabis and other substances have been shown to have higher 
mental illness co morbidity rates than alcohol. (86).  
5.9 Impact of Type of Psychotic Disorder 
The major differences between the groups were portrayed between the alcohol and 
no substance abuse group. This identifies that individuals falling within the no substance 
group had the lowest level of activity participation and performed poorly across all eight 
domains. This may be attributed to the type of diagnosis present within this group and 
not merely the absence of substances.  
The lower level of activity participation within the no substance abuse group appears 
to be linked to the type of diagnosis associated with this group as all the participants were 
diagnosed with schizophrenia. This supports the criteria put forward by the DSM-IV which 
indicates that individuals diagnosed with schizophrenia will experience a chronic and 
deteriorating level of activity participation throughout their lifespan. However, the 
symptoms experienced by an individual diagnosed with substance induced psychosis 
should subside relatively quickly after the cessation of the substance and the individual 
should then return to baseline level of functioning. (6) This is portrayed by the APOM 
scores as those individuals diagnosed with substance induced psychosis performed better 
across all domains compared to those diagnosed with schizophrenia. This infers that 
clinicians will need to take into consideration the type of psychiatric diagnosis as well as 
type of substance when considering an individual’s prognosis and goals for intervention.  
5.10 Level of Activity Participation in Dual Diagnosis 
Chronic use of alcohol and cannabis has been shown in past literature to cause 
cognitive impairments in adults.(21) Studies which have been conducted within the last 
five years, have indicated that amongst both healthy individuals and patients with 
schizophrenia, there appears to be little difference in cognitive performance between 
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cannabis users and non-users. This research is therefore suggesting that cannabis use has 
only subtle effects on the neurocognitive performance (58, 59) and that co morbid 
alcohol or cannabis abuse or dependence has limited effects on cognitive performance in 
individuals already presenting with a psychotic disorder.(57)  
The MOCA is a screening tool used to assess an individual’s basic cognitive functions. 
This tool was used to assist the researcher with levelling the client on the APOM in terms 
of their process skills. 
 The MOCA was unable to determine statistically significant differences amongst the 
three groups which could be an indication that the MOCA is not a sensitive enough tool to 
note changes in an individual’s cognitive functions within the mental health population. It 
is therefore, not possible to use this data to accurately compare the cognitive functions 
between the three groups. The MOCAs limitations in terms of sensitivity need to be noted 
as it is been described only as a screening tool and therefore the results cannot be 
inferred as a full accurate assessment of all cognitive functions. It can however, be stated 
that across all three groups the average scores were below the expected norm for an 
adult population and overall the cannabis group was levelled as having a slightly better 
cognitive performance than the no substance group diagnosed with schizophrenia. 
The more reliable data which can be used to correlate similar trends as noted in the 
recent literature is the total APOM scores or the individual’s overall level of occupational 
performance. When comparing the total APOM scores against schizophrenia and 
substance induced psychosis within each of the three groups, it was noted that the 
cannabis group diagnosed with schizophrenia did achieve a slightly higher level of activity 
participation than the no substance abuse group or purely schizophrenia diagnosis group. 
The degree of difference is not significant but the data does correlate to the research 
indicating that cannabis may only have subtle effects on the level of activity participation 
in individuals who are diagnosed already with schizophrenia. 
A greater degree of difference was actually noted in the alcohol group. Participants 
diagnosed with alcohol abuse and schizophrenia performed better than both the no 
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substance abuse group and the cannabis group diagnosed with schizophrenia. This infers 
that alcohol may have a lower impact on affecting a participant’s level of activity 
participation when compared to cannabis and schizophrenia. The current age of the 
participants needs to be considered as the current limited cognitive decline may be due 
to the alcohol use occurring when the individual is in early adulthood and long term 
consequences may only be more profound into late adulthood. There is also the 
possibility of the participants within the cannabis and alcohol abuse group having a lower 
vulnerability to psychosis and a better response to psychotropic medication which may be 
the reason behind the better cognitive performance. It should also, however, be noted 
that there was a decreased number of participants in the alcohol group compared to the 
other two groups and this limits the reliability of the information.  
5.11 Limitations of Study 
The practical difficulties of accessing drug testing before each functional assessment 
made the ability to determine whether the participant was under the influence of 
substances subjective. The use of substances might have been “missed” which could have 
impacted on the scores obtained from the APOM measure. This could possibly lead to the 
scores attributed to the client’s level of activity participation being of a lower level than 
what would be actually presented by the client as the client at the time of the assessment 
was under the influence of substances. This may therefore have produced inaccurate 
results. 
A small sample size provided the researcher only with enough supporting evidence to 
reject the null hypothesis of this study. The findings may be generalised to the population 
at CHBAH. This study can however be repeated in similar settings and findings be 
compared.  There were certain difficulties around diagnosing participants either 
substance abuse or substance dependence and this may have hindered the validity of the 
data in terms of level of substance use. 
The participant’s level of education was not considered and this may have had an 




The above chapter discussed the major findings and implications from the previously 
put forward results. The following chapter will provide the implications for practice as 


















CHAPTER 6  Conclusion 
 
1. Introduction 
The impact of adolescence initiated alcohol and cannabis abuse/dependence on the 
level of adulthood activity participation in the CHBAH male population, was the main 
question put forward by the researcher. The researcher has achieved this objective by 
both determining the impact of both substances and comparing the differences on the 
level of activity participation. In keeping with the literature that states that cannabis and 
alcohol abuse does have negative consequences on an individual’s level of functioning, 
this research study has proved that there is a decline in the level of activity participation 
by the APOM scores. This research report has put forward the methodology, results and 
key discussion points noted from the study. This chapter will conclude the main trends as 
well as the implications for practice and recommendations. 
2. Implications for Clinical Practice and Recommendations 
As a result of what has been discussed the following recommendations for clinical 
practice are put forward.  
Alcohol abuse, cannabis abuse and schizophrenia have all shown in this research 
study, to have a negative impact on an individual’s level of activity participation. Cannabis 
appears to have a more profound negative impact on activity participation as compared 
to alcohol, with domains such as motivation, balanced lifestyle and self esteem being the 
most affected. Schizophrenia appears to have the most detrimental impact compared to 
both cannabis and alcohol. Occupational therapists should therefore take into 
consideration the type of substance that the individual is using, when they started using 
and the type of psychiatric disorder, in order to be able to tailor a more realistic and 
specific intervention programme. The development of intervention programmes based on 
the individuals APOM levels may also produce better occupational outcomes as the 
individuals within such a programme will have similar occupational and cognitive 
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functioning levels. Placing individuals within a programme where the substance of choice, 
diagnosis and APOM level are similar will facilitate stronger cohesion and promote 
positive support systems in order to improve occupational performance and prevent 
relapse. 
The use of the APOM as an outcome measure acted as a sound recording tool for the 
occupational therapy assessment in this research study. The information obtained was 
easy to understand and the values allowed the researcher to accurately compare the level 
of activity participation between the different substance and diagnoses. The use of 
numerical values to convey occupational performance allowed for better communication 
amongst the multidisciplinary team and it provided the participants with a concrete 
measure of their performance. The importance of occupational therapists documenting 
or recording their intervention has become an area of focus within the last few years 
owing to the proposed implementation of National Health Insurance. It is therefore 
recommended that occupational therapists incorporate an outcome measure into their 
intervention with each patient and to consider using the APOM as the recording tool as it 
has proved to be reliable, valid and efficient. 
Within the clinical setting, due to the limited bed space available at CHBAH, there is a 
high turnover of patients and this leads to individual’s being discharged on the APOM 
level of six to nine which poses serious negative implications on the individual and his/her 
family. These individuals have limited insight into their condition and are not able to 
engage in the open labour market. This creates the revolving door syndrome in that 
individual’s have numerous readmissions as they are discharged at a stage when they do 
not yet fully understand their psychiatric disorder and this leads to them defaulting on 
their medication or returning to abuse substances. Occupational therapists need to be 
aware of these practical difficulties within a government setting and ensure that 
adequate follow up or family intervention is executed. Community resource centres, 
nongovernmental organizations (e.g. SANCA) and protective workshops should be utilised 
in order to promote better or maintain current occupational performance after discharge 
and prevent further relapse. 
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The ability for occupational therapists to be involved in community prevention 
programs is also promoted through this research, as the occupational therapist would be 
able to indicate the consequences of substance abuse to the adolescent population. The 
APOM allows for an easy to understand representation of the negative impact on life 
skills and it can be presented that the study participants were all South African citizens. 
This may facilitate stronger buy in from the South African youth and promote abstinence 
from substances.  
3. Conclusion 
Substance abuse has been documented in the literature to have serious adverse 
affects on an individual’s occupational and social functioning. Limited evidence was 
present within the South African population to demonstrate these effects and to establish 
exactly which skills are more or less affected.  
From this study, it can be inferred that early substance abuse does have a negative 
effect on an individual’s level of activity participation into adulthood. The earlier an 
individual initiates the substance use the increased number of developing skills are 
affected and as a result poorer occupational outcomes are noted in adulthood. Within the 
sample, cannabis use was started at a younger age and an increased number of 
participants utilized more cannabis as compared to alcohol. This is attributed to reduced 
costs, easy accessibility and cultural acceptance of cannabis use for individuals between 
the ages of 15 – 30 years. Cannabis compared to alcohol, demonstrated to have a more 
negative and severe impact on the level of performance. When cannabis and alcohol 
abuse was compounded with schizophrenia it did not appear to further reduce the level 
of activity participation but rather individual’s only diagnosed with schizophrenia showed 
to have a lower level of activity participation. 
Within the South African context, it is highly probable that substance abuse will 
continue to be a major problem amongst the youth and young adult populations. The 
ever increasing use of substances will lead to an increase in mental illness as well as 
deterioration in occupational performance. Occupational therapists are well equipped to 
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assist these individuals as they are specifically trained to gain a holistic view of both the 
person and their environment. This is a vital connection and forms an interlinking cycle 
when addressing substance abuse disorders. Holistic, specific and occupation based 
interventions programmes, will promote a better prognosis for these individuals, diminish 
the negative consequences of substances and provide individuals with the skills to 
achieve their highest level of occupational performance.  
 
 
God grant me the serenity 
to accept the things I cannot change; 
courage to change the things I can; 




1. Drake R. Dual Diagnosis. Psychiatry 2007;6(9):381-4. 
2. Dixon L. Dual diagnosis of substance abuse in schizophrenia: prevalence and impact 
on outcomes. Schizophrenia Research 1999;35(1):S93-S100. 
3. Meek PS, Clark HW, Solana VL. Neurocognitive Impairment: The Unrecognized 
Component of Dual Diagnosis in Substance Abuse Treatment. Journal of Psychoactive 
Drugs 1989;21(2):153-60. 
4. Brown SA, Tapert SF. Adolescence and the trajectory of alcohol use: basic to clinical 
studies. Academy of Sciences 2004;1021:234-44. 
5. Stein D, Herman A, Moomal H, Heeringa SG, Kessler RC, Williams DR. Lifetime 
prevalence of psychiatric disorders in South Africa. British Journal of Psychiatry 
2008;192(1):112-7. 
6. Robertson B, Allwood C, Gagiano C. Textbook of Psychiatry for Southern Africa. 1 ed. 
Oxford, New York: Oxford University Press; 2001 2001. 196 - 8 p. 
7. Report TUNWD. The United Nations World Drug Report. 2011; Available from: 
http://www.unodc.org/documents/data-and-analysis/WDR2011/ 
World_Drug_Report_2011 ebook.pdf 
8. Hall W, Degenhardt, L. Adverse health effects of non-medical cannabis use. The 
Lancet 2009;374(9698):1383-91. 
9. Parry CD, Pluddemann A, Steyn K, Bradshaw D, Norman R, Laubscher R. Alcohol Use 
in South Africa: Findings from the First Demographic and Health Survey. Journal of 
Studies on Alcohol and Drugs  2005;66(1):91-7. 
10. Reddy SP, Panday S, Swart D, Jinabhai CC, Amosun SL, James S et al. Umthenthe 
Uhlaba Usamila - The South African Youth Risk Behaviour Survey 2002. Cape Town: 
South African Medical Research Council, 2003.  Available from: 
ttp://www.mrc.ac.za/healthpromotion/YRBSpart1.pdf 
11. Pitkänen T, Pulkkinen L. Age of onset of drinking and the use of alcohol in adulthood: 
A follow-up study from age 8-42 for females and males. Addiction 2005;100:652–61. 
12. Bonomo L, Coffey C, Carlin JB, Patton GC. Teenage drinking and the onset of alcohol 
dependence: A cohort study over seven years. Addiction  2004;99:1520–8. 
13. Sadock B, Saddock V. Synopsis of Psychiatry: Behavioral Sciences/ Clinical Psychaitry. 
10 ed. New York: Lippincott Williams and Wilkins; 2007. 
14. Martin C, Chung T, Langenbucher J. How should we revise diagnostic criteria for 
substance use disorders in the DSM-V? Journal of Abnormal Psychology 
2008;117(3):561-75. 
15. American Psychiatric Association. Substance-Related and Addictive Disorders 
America: American Psychiatric Publishing; 2013 [cited 2014 03/08/2014]. 
16. Grant JD, Scherrer JF, Lynskey MT, Lyons MJ, Eisen SA, Tsuang MT et al. Adolescent 
alcohol use is a risk factor for adult alcohol and drug dependence: evidence from a 
twin design. Psychological Medicine 2006;36(1):109-18. 
17. Crouch R, Alers V. Occupational Therapy in Psychiatry and Mental Health. London: 
Whurr Publishers; 2005. 
 58 
 
18. Guerri C, Pascual M. Mechanisms involved in the neurotoxic, cognitive, and 
neurobehavioral effects of alcohol consumption during adolescence. Alcohol 
2010;44(1):15-26.  
19. Bates ME, Labouvie E. Adolescent risk factors and the prediction of persistent alcohol 
and drug use into adulthood. Alcoholism, clinical and experimental research 
1997;21(5):944-50. 
20. Best D, Gross S, Manning V, Gossop M, Witton J, Strang J. Cannabis use in 
adolescents: the impact of risk and protective factors and social functioning. Drug 
and Alcohol Review  2005;24(6):483-8. 
21. Thoma RJ, Monnig MA, Lysne PA, Ruhl DA, Pommy JA, Bogenschutz M et al. 
Adolescent substance abuse: the effects of alcohol and marijuana on 
neuropsychological performance. Alcoholism: Clinical and Experimental Research 
2011;35(1):39-46. 
22. American Academy of Child and Adolescent Psychiatry. Teens: Alcohol And Other 
Drugs. [Online] Available from: 
http://aacap.org/page.ww?name=Teens:+Alcohol+and+Other+Drugs&section=Facts+
for+Families [Accesed 10th July2011] 
23. Iso-Ahola SE, Crowley ED. Adolescent Substance Abuse and Leisure Boredom. Journal 
of Leisure Research 1991;23(3):260-71. 
24. Sharp E, Coffman D, Caldwell L, Smith E, Wegner L, Vergnani T, Mathews C. Predicting 
substance use behavior among South African adolescents: The role of leisure 
experiences across time. International Journal of Behavioral Development 
2011;35(4):343-51. 
25. Spano MS, Fadda P, Fratta W, Fattore L. Cannabinoid-opioid interactions in drug 
discrimination and self-administration: effect of maternal, postnatal, adolescent and 
adult exposure to the drugs. Current Drug Targets  2010;11(4):450-61. 
26. Clark DB, Thatcher DL, Tapert SF. Alcohol, psychological dysregulation, and 
adolescent brain development. Alcoholism, clinical and experimental research. 
2008;32(3):375-85.  
27. Bartley PC, Rezvani AH. Alcohol and cognition - consideration of age of initiation, 
usage patterns and gender: a brief review. Current drug abuse reviews  2012;5(2):87-
97.  
28. Maldonado-Devincci AM, Badanich KA, Kirstein CL. Alcohol during adolescence 
selectively alters immediate and long-term behavior and neurochemistry. Alcohol 
2010;44(1):57-66. 
29. Goldman MS, Williams DL, Klisz DK. Recoverability of psychological functioning 
following alcohol abuse: prolonged visual-spatial dysfunction in older alcoholics. 
Journal of consulting and clinical psychology  1983;51(3):370-8.  
30. Levola J, Aalto M, Holopainen A, Cieza A, Pitkänen T. Health-related quality of life in 
alcohol dependence: A systematic literature review with a specific focus on the role 
of depression and other psychopathology. Nordic Journal of Psychiatry  2014(68); 
369-384. 
31. Volk RJ, Cantor SB, Steinbauer JR, Cass AR. Alcohol Use Disorders, Consumption 
Patterns, and Health-Related Quality of Life of Primary Care Patients. Alcoholism: 
Clinical and Experimental Research  1997;21(5):899-905. 
 59 
 
32. Hendrie HC, Gao S, Hall KS, Hui SL, Unverzagt FW. The relationship between alcohol 
consumption, cognitive performance, and daily functioning in an urban sample of 
older black Americans. Journal of the American Geriatric Society  1996;44(10):1158-
65. 
33. Newcomb MD, Bentler PM. Impact of adolescent drug use and social support on 
problems of young adults: A longitudinal study. Journal of Abnormal Psychology 
1988;97(1):64-75. 
34. Brook JS, Balka EB, Whiteman M. The risks for late adolescence of early adolescent 
marijuana use. American Journal of Public Health 1999;89(10):1549-54. 
35. Brook JS, Lee JY, Brown EN, Finch SJ, Brook DW. Developmental trajectories of 
marijuana use from adolescence to adulthood: personality and social role outcomes. 
Psychological Reports  2011;108(2):339-57. 
36. Fergusson DM, Horwood LJ, Swain-Campbell NR. Cannabis use and psychosocial 
adjustment in adolescence and young adulthood. Addiction  2002;97(9):1123-
35Solowij N, Stephens RS, Roffman RA. Cognitive functioning of long-term heavy 
cannabis users seeking treatment. Journal of the American Medical Association 
2002;287(9):1123-31. 
37. Brook JS, Adams RE, Balka EB, Johnson E. Early adolescent marijuana use: risks for the 
transition to young adulthood. Psychological Medicine  2002;32(1):79-91. 
38. Fergusson DM, Boden JM. Cannabis use and later life outcomes. Addiction 
2008;103(6):969-76. 
39. Fergusson DM, Horwood LJ, Beautrais AL. Cannabis and educational achievement. 
Addiction  2003;98(12):1681-92. 
40. Solowij N, Stephens RS, Roffman RA. Cognitive functioning of long-term heavy 
cannabis users seeking treatment. Journal of the American Medical Association 
2002;287(9):1123-31. 
41. Jacobsen LK, Mencl WE, Westerveld M, Pugh KR. Impact of Cannabis Use on Brain 
Function in Adolescents. Annals of the New York Academy of Sciences 
2004;1021(1):384-90. 
42. Baumrind K, Moselle A. A development perspective on adolescent drug abuse. 
Advances in Alcohol & Substance Abuse 1985;4(3-4):41-66. 
43. Lynskey M, Hall W. The effects of adolescent cannabis use on educational 
attainment: a review. Addiction  2000;95(11):1621-30. 
44. Smith J, Hucker S. Schizophrenia and substance abuse. The British Journal of 
Psychiatry. 1994;165(1):13 to 21. 
45. Alers V, Crouch R. Occupational Therapy: An African Perspective. Johannesburg: 
Sarah Shorten Publishers; 2010. 
46. Shrier LA, Harris SK, Kurland M, Knight JR. Substance use problems and associated 
psychiatric symptoms among adolescents in primary care. Peadiatrics  2003;111:699-
705. 
47. Compton MT, Kelley ME, Ramsay CE,  Pringle M,  Goulding SM,  Esterberg ML et al. 
Association of Pre-Onset Cannabis, Alcohol, and Tobacco Use with Age at Onset of 
Prodrome and Age at Onset of Psychosis in First-Episode Patients. American Journal 
Psychiatry  2009;166:1251–7. 
 60 
 
48. Deas D. Adolescent substance abuse and psychiatric comorbidities. Journal of Clinical 
Psychiatry  2006;67(7):18-23. 
49. Hasin DS, Stinson FS, Ogburn E, Grant BF. Prevalence, correlates, disability, and 
comorbidity of DSM-IV alcohol abuse and dependence in the United States: results 
from the National Epidemiologic Survey on Alcohol and Related Conditions.  Archives 
of General Psychiatry  2007;64(7):830-42. 
50. The American Heritage® Medical Dictionary. Houghton Mifflin Company; 2007. 
[Online] Available from: http://medical-dictionary.thefreedictionary.com/psychosis 
[Accesed 10th July 2011]  
51. Bowie CR, Harvey PD. Cognition in schizophrenia: impairments, determinants, and 
functional importance. Psychiatric Clinics of North America  2005;28(3):613-33. 
52. Tsang HWH, Leung AY, Chung RCK, Bell M, Cheung W. Review on vocational 
predictors: a systematic review of predictors of vocational outcomes among 
individuals with schizophrenia: an update since 1998. Australian & New Zealand 
Journal of Psychiatry  2010;44(5):495-504. 
53. Donohoe G, Corvin A, Robertson IH. Are the cognitive deficits associated with 
impaired insight in schizophrenia specific to executive task performance? Journal of 
Nervous and Mental Disease  2005;193(12):803-8. 
54. Leitman PS, Higgins B, Foxe J, Silipo G,  Javitt D. Sensory Deficits and Distributed 
Hierarchical Dysfunction in Schizophrenia. American Journal of Psychiatry 
2010;167:818-27. 
55. Ursu S, Kring AM, Gard MG, Minzenberg MJ, Michael J, Yoon JH et al.  Prefrontal and 
Cortical Deficits and Impaired Cognition-Emotion Interactions in Schizophrenia. 
American Journal of Psychiatry  2011;168:276-85. 
56. Sparks A, McDonald S, Lino B, O'Donnell M, Green MJ. Social cognition, empathy and 
functional outcome in schizophrenia. Schizophrenia Research  2010;122(1-3):172-8. 
57. Liraud F, Verdoux H. Effect of comorbid substance use on neuropsychological 
performance in subjects with psychotic or mood disorders. Encephale 
2002;28(2):160-8. 
58. Schnell T, Koethe D, Daumann J, Gouzoulis-Mayfrank E. The role of cannabis in 
cognitive functioning of patients with schizophrenia. Psychopharmacology 
2009;205(1):45-52. 
59. Scholes KE, Martin-Iverson MT. Cannabis use and neuropsychological performance in 
healthy individuals and patients with schizophrenia. Psychological Medicine 
2010;40(10):1635-46. 
60. Yücel M, Bora E, Lubman DI, Solowij N, Brewer WJ, Cotton SM et al. The Impact of 
Cannabis Use on Cognitive Functioning in Patients With Schizophrenia: A Meta-
analysis of Existing Findings and New Data in a First-Episode Sample. Schizophrenia 
Bulletin  2012;38(2):316-30. 
61. Smith E, Palen L-A, Caldwell L, Flisher A, Graham J, Mathews C et al. Substance Use 
and Sexual Risk Prevention in Cape Town, South Africa: An Evaluation of the 
HealthWise Program. Prevention Science  2008;9(4):311-21. 
62. Larimer ME, Cronce JM. Identification, prevention and treatment: a review of 
individual-focused strategies to reduce problematic alcohol consumption by college 
students. Journal of studies on alcohol (Supplement)  2002(14):148-63.  
 61 
 
63. Magura S, Cleland CM, Tonigan JS. Evaluating Alcoholics Anonymous's effect on 
drinking in Project MATCH using cross-lagged regression panel analysis. Journal of 
Studies on Alcohol and Drugs 2013;74(3):378-85. 
64. Weisner C, Mertens J, Tam T, Moore C. Factors affecting the initiation of substance 
abuse treatment in managed care. Addiction  2001;96(5):705-16. 
65. Le Berre AP, Rauchs G, La Joie R, Segobin S, Mezenqe F, Boudehent C et al.  Readiness 
to change and brain damage in patients with chronic alcoholism. Psychiatry research  
2013;213(3):202-9.  
66. Kim KM, Kim JS, Kim GJ, Kim SS, Jung JG, Kim SM et al. The readiness to change and 
insight in alcohol dependent patients. Journal of Korean Medical Science  
2007;22(3):453-8.  
67. Twamley EW, Jeste DV, Bellack AS. A review of cognitive training in schizophrenia. 
Schizophrenia Bulletin  2003;29(2):359-82. 
68. Lefio LA, Villarroel SR, Rebolledo C, Zamorano P, Rivas K. Effective interventions in 
the problematic use of alhocol and other drugs. Revista Panamericana de Salud 
Pública  2013;34:257-66. 
69. Falloon IRH, Held T, Roncone R, Coverdale JH, Laidlaw TM. Optimal treatment 
strategies to enhance recovery from schizophrenia. Australian & New Zealand 
Journal of Psychiatry  1998;31(1):43-9. 
70. Bustillo J, Lauriello J, Horan W, Keith S. The psychosocial treatment of schizophrenia: 
an update. American Journal of Psychiatry  2001;158(2):163-75. 
71. Korn C. A Psycho educational Program for the Chronically Mentally Ill. [Online] 
Available from: http://cme.medscape.com/viewarticle/418620  [Accessed 29th June 
2009] 
72. Rund BR, Moe L, Sollien T, Fjell A, Borchgrevink T, Hallert M et al. The Psychosis 
Project: outcome and cost-effectiveness of a psycho educational treatment 
programme for schizophrenic adolescents. Acta Physchiatrica Scandanavica 
2007;83:211-8. 
73. Poon MY, Siu AM, Ming SY. Outcome analysis of occupational therapy programme for 
persons with early psychosis. Work  2010;37(1):65-70. 
74. Buchain PC, Vizzotto ADB, Henna Neto J, Elkis H. Randomized controlled trial of 
occupational therapy in patients with treatment-resistant schizophrenia. Revista 
Brasileira de Psiquiatria 2003;25(1):26-30. 
75. Mahoney JL, Stattin H. Leisure activities and adolescent antisocial behavior: The role 
of structure and social context. Journal of adolescence  2000(2):113 – 27. 
76. Kavanagh DJ, Waghorn G, Jenner L, Chant DC, Carr V, Evans E et al. Demographic and 
clinical correlates of comorbid substance use disorders in psychosis: multivariate 
analyses from an epidemiological sample. Schizophrenia Research  2004;66(6):115 - 
24. 
77. Nasreddine ZS, Phillips NA, Bédirian V, Charbonneau S, Whitehead V, Collin I et al. 
The Montreal Cognitive Assessment, MoCA: A Brief Screening Tool For Mild Cognitive 
Impairment. Journal of the American Geriatrics Society  2005;53(4):695-9. 
78. Smith T, Gildeh N, Holmes C. The Montreal Cognitive Assessment: Validity and Utility 
in a Memory Clinic Setting. La Revue canadienne de psychiatrie  2007;52(5). 
 62 
 
79. Casteleijn D. Development of an outcome measure for occupational therapists in 
mental healthcare practices. PhD thesis: University of Pretoria, South Africa; 2010. 
Available from: upetd.up.ac.za/thesis/available/etd-02102011-143303/ 
80. Merikangas KR, Mehta RL, Molnar BE, Wlaters EE, Swendsen JD, Aquilar-Gaziola S et 
al. Comorbidity of substance use disorders with mood and anxiety disorders: Results 
of the international consortium in psychiatric epidemiology. Addictive Behaviors  
1998;23(6):893-907. 
81. Malose L. The prevalence of alcohol and other drug use amongst school learners in 
Alexandra Township. Wits Institutional Repository environment on WIReDSpace: 
Witwatersrand; 2006. Available from http://hdl.handle.net/10539/241 
82. Steinberg L. Cognitive and affective development in adolescence. Trends in Cognitive 
Sciences  2005;9(2):69-74. 
83. Wegner L, Fsisher A. Leisure boredom and adolescent risk behaviour: a systematic 
literature review. Journal of Child & Adolescent Mental Health  2009;1(21):1-29. 
84. Sullivan EV, Rosenbloom MJ, Pfefferbaum A. Pattern of Motor and Cognitive Deficits 
in Detoxified Alcoholic Men. Alcoholism: Clinical and Experimental Research  
2000;24(5):611-21. 
85. Andréasson S, Allebeck P, Engstrom A, Rydberg U. Cannabis ans Schizophrenia. A 
Longitudinal Study of Swedish Conscripts. The Lancet  1987;330(8574):1483-6. 
86. Regier DA, Farmer ME, Rae DS, Locke BZ, Keith SJ, Judd LL, Goodwin FK. Comorbidity 
of mental disorders with alcohol and other drug abuse: Results from the 
epidemiologic catchment area (eca) study. Journal of the American Medical 




















































Classification of Group 
 (To be completed by researcher) 
Participant number: 




Psychotic psychiatric diagnosis: 








Type of substance: 
Cannabis  Alcohol  None  
 
 (If none selected than following on questions are not applicable) 
 





Level of use of substance: 
Abuse  Dependence  
 
Additional: Specify type of substance & quantity of use 
_____________________________________________________________ 
Participant Demographic Information 





Home Environment/Support systems: (Positive or Negative) 
_______________________________________________________________ 
Developmental History: (Any problems noted during childhood?) 
____________________________________________________________ 
Highest Level of Education: 
______________________________________________________________ 
School Performance: (Any problems noted during school years?) 
_______________________________________________________________ 




Socioeconomic Status: (H0, H1, H2, Private) 
_______________________________________________________________ 
Family History of Substance Abuse: (Yes/No) 
_______________________________________________________________ 
Number of Previous Hospitalizations/Rehabilitation admittance: 
_______________________________________________________________ 



















Study Title: The impact of adolescence initiated alcohol and cannabis use on 
the level of activity participation in adult males suffering from a psychotic disorder.  
Investigator: This information details the research being undertaken by Kristyn 
Wolhuter who is interested in determining the impact of adolescence substance 
abuse on the level of adult activity participation for an MSc degree in Occupational 
Therapy. 
Institution: University of the Witwatersrand 
Researcher’s Contact Details:  
011 933 9054 (Work hours) / 082 487 2361 (After hours) 












Participant Information sheet 
Good Day, 
My name is Kristyn Wolhuter and I am both a full time occupational therapist at 
Chris Hani Baragwanath Academic Hospital as well as a part time MSc OT student 
at the University of the Witwatersrand.  I wish to invite you to consider participating 
in a research study, entitled “The impact of adolescence initiated alcohol and 
cannabis use on the level of activity participation in adult males suffering from a 
psychotic disorder.” 
There is currently very little research into how certain substances (cannabis 
and alcohol) affects various areas of people’s lives such as work, leisure, hygiene 
and social skills and how these substances affect individuals already suffering 
from a mental illness. The purpose of this study is to develop a better 
understanding of the negative impact of substance abuse in individuals suffering 
from a mental disorder within the South African context. I hope that through these 
findings the occupational therapy treatment programmes may become more 
effective and more specific to people suffering from both a substance abuse 
problem and a mental illness. 
In order to gain an understanding of the long term consequences of the 
substance abuse or mental illness, an occupational therapy assessment will be 
done.  Each participant shall be placed into one of three groups, one of which will 
consist of people who misuse alcohol, a group of cannabis abusers and a group of 
individuals who do not abuse substances. These three groups will then be 
compared to determine the similarities and differences. This will be done by 
starting off with a five minute interview to gain some information about you and 
your health. This will be followed by a series of short activities which will require 
your active participation. Some examples of these activities include:  making a 
paper box, beading a bracelet, threading a toiletry bag, etc. Each activity will be 
chosen depending on your experience in that activity and your current level of 
ability or skill. Whilst you are completing the activity, the researcher will note how 
you perform the task and input the information onto a computer based system 
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called the Activity Participation Outcome Measure. This programme will generate a 
score of the performance which will be analysed with other participant’s scores to 
determine what the similarities and differences are between the three groups.  
The whole assessment will take approximately 3 hours to complete but the 
assessment does not need to be completed in one day and may be carried over to 
2 or 3 more sessions if necessary.  
There are no known risks, discomforts or side effects from participating in the 
study.  
Your participation in this study is entirely voluntary and you may decline to 
participate or stop at any time, without stating a reason. Declining to participate will 
not result in any penalties or loss of benefits. Should you not wish to participate 
and an occupational therapy assessment was requested by another health 
professional, a full assessment will still be conducted but the information from the 
assessment would not be used for research purposes or included in this study. 
All information obtained during the course of the study, including hospital 
records, personal information and research data will be kept strictly confidential. 
The confidentiality will be maintained by using a code instead of your name so that 
you cannot be identified. All written research data (paper based) will be securely 
stored in a locked cabinet accessible only to the researcher. The recorded 
computer based information will be password protected and known only to the 
researcher. 
If you have any questions or need more information please don’t hesitate to 
contact, Kristyn Wolhuter, at (011) 933 9054 or 082 487 2361. Please contact me 
telephonically if you wish to receive feedback about the study and the research 
findings. 
If you are happy to participate in my study, please read and sign the attached 
consent form. 





I agree to participate in the study, “The impact of adolescence initiated alcohol 
and cannabis abuse/dependence on the level of activity participation in adult 










































Research Committee: Chris Hani Baragwanath Academic Hospital 
25/01/2012 
Re: Permission to conduct research 
To whom it may concern, 
My name is Kristyn Wolhuter and I am both a full time occupational therapist at 
Chris Hani Baragwanath Academic Hospital as well as a part time MSc OT student 
at the University of the Witwatersrand.  I am requesting to conduct my research 
study, entitled “The impact of adolescence initiated alcohol and cannabis use on 
the level of activity participation in adult males suffering from a psychotic disorder” 
at Chris Hani Baragwanath Academic Hospital. 
The purpose of this study is to develop a better understanding of the long term 
consequences of substance abuse in individuals suffering from a psychotic 
disorder. This will be achieved through comparing the level of functioning between 
individuals suffering from a psychotic disorder and those that suffer from a 
psychotic disorder but also abuse cannabis or alcohol. I hope that through these 
findings the occupational therapy treatment programmes may become more 
evidence based and specific to people suffering from both a substance abuse 
problem and a psychotic disorder. 
In order to determine a holistic view of the long term consequences of the 
substance abuse or psychotic disorder, an occupational therapy assessment will 
be done.  A brief five minute initial interview will be done in order to gain basic 
demographic and medical information. This will be followed by a series of short 
activities such as making a paper box, beading a bracelet, threading a toiletry bag, 
etc. Whilst each participant is completing the activity, the researcher will note how 
they perform the task and put in their level of performance onto a computer based 
system called the Activity Participation Outcome Measure (APOM). This 
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programme will generate a score of the performance which will be analysed with 
other participant’s scores to determine if there is any significant difference as well 
as performance similarities and differences. The participant’s scores shall be 
compared in terms of three groups including alcohol abuse/dependence, cannabis 
abuse/dependence or no substance abuse/dependence. 
Informed consent and confidentiality will be ensured with every participant. The 
results from the study will be submitted in a research report which will be handed 
in to the University of the Witwatersrand for the completion of the MSc OT degree.  
Ethical clearance (to be completed once ethical clearance from Wits University 
has been received) 
If you have any questions or need more information please don’t hesitate to 
contact me at: 




Operational Occupational Therapist 
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